Clinical Trials
12
Active:2
Completed:10
Trial Phases
1 Phases
Not Applicable:3
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials
Not Applicable
3 (100.0%)CardioSeq: Impact of WGS in Individuals With CVD
Not Applicable
Active, not recruiting
- Conditions
- Cardiovascular Diseases
- First Posted Date
- 2022-12-19
- Last Posted Date
- 2024-04-30
- Lead Sponsor
- Illumina, Inc.
- Target Recruit Count
- 1500
- Registration Number
- NCT05656183
- Locations
- 🇺🇸
Henry Ford Health System, Detroit, Michigan, United States
iKnow: A Prospective Study to Evaluate the Use of Multi-omics in Multi-System, Early Onset Disorders
Active, not recruiting
- Conditions
- Genetic Disease
- First Posted Date
- 2021-09-20
- Last Posted Date
- 2024-04-30
- Lead Sponsor
- Illumina, Inc.
- Target Recruit Count
- 150
- Registration Number
- NCT05049967
- Locations
- 🇺🇸
Clinic for Special Children, Strasburg, Pennsylvania, United States
Evaluation of the COVIDSeq Test in Saliva Specimens From COVID-19 Asymptomatic Illumina Personnel
Completed
- Conditions
- SARS-CoV-2
- First Posted Date
- 2020-09-23
- Last Posted Date
- 2022-01-21
- Lead Sponsor
- Illumina, Inc.
- Target Recruit Count
- 763
- Registration Number
- NCT04561089
- Locations
- 🇺🇸
Illumina Laboratory Services, San Diego, California, United States
🇺🇸Illumina Hayward, Hayward, California, United States
Evaluation of the COVIDSeq Test in Nasal Swab and Saliva From a COVID-19 Asymptomatic Population
Completed
- Conditions
- SARS-CoV-2
- First Posted Date
- 2020-09-23
- Last Posted Date
- 2022-01-21
- Lead Sponsor
- Illumina, Inc.
- Target Recruit Count
- 644
- Registration Number
- NCT04561102
- Locations
- 🇺🇸
Rollins College Alfonds Sports Center, Winter Park, Florida, United States
NeuroSeq: A Prospective Trial to Evaluate the Diagnostic Yield of Whole Genome Sequencing (WGS) in Adult Neurology
Completed
- Conditions
- Neurologic AbnormalitiesNeurologic DisorderNeurologic Deficits
- First Posted Date
- 2019-11-20
- Last Posted Date
- 2024-05-01
- Lead Sponsor
- Illumina, Inc.
- Target Recruit Count
- 160
- Registration Number
- NCT04170985
- Locations
- 🇺🇸
Univ. of Pennsylvania, Philadelphia, Pennsylvania, United States
- Prev
- 1
- 2
- 3
- Next
News
No news found